Syncom Formulations Announces Dual Leadership Resignations: CFO and Whole-time Director Step Down Aug 18, 2025
More news about Syncom Formulations
08Aug 25
Syncom Formulations Reports Strong Q1 Growth with Revenue Up 34% and Net Profit Doubling
Syncom Formulations (India) Limited reported impressive Q1 financial results. Revenue from operations increased by 34% to ₹11,654.69 crore, while net profit more than doubled to ₹1,572.93 crore, marking a 106% growth. EBITDA rose by 85% to ₹2,179.44 crore, with an improved EBITDA margin of 18.70%. The company's board announced several key appointments and leadership changes, including the re-designation of Shri Kedarmal Shankarlal Bankda and the appointment of Shri Ankit Kedarmal Bankda as Chairman and Whole Time Director. The 37th AGM is scheduled for September 29.
20May 25
Syncom Formulations Reports Impressive Q4 Results with Soaring Profits and Revenue
Syncom Formulations announced impressive Q4 financial results. Net profit soared 159.26% year-over-year to ₹175.00 crore, up 36.72% quarter-over-quarter. Revenue reached ₹1,500.00 crore, a 104.72% increase from the previous year. The company's strong performance indicates effective business strategies and high market demand for its products.
19May 25
Syncom Formulations Reports Impressive Q4 Financial Results with Substantial Growth
Syncom Formulations announced impressive Q4 financial results, with revenue soaring 104% year-over-year to ₹1,500.00 crore. Net profit surged 159% to ₹175.00 crore, while EBITDA nearly doubled to ₹175.00 crore. Despite strong overall performance, EBITDA margin slightly decreased to 11.67% from 12.02% in the previous year.